Works matching IS 0167594X AND DT 2016 AND VI 127 AND IP 3


Results: 24
    1

    Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system.

    Published in:
    Journal of Neuro-Oncology, 2016, v. 127, n. 3, p. 435, doi. 10.1007/s11060-015-2052-2
    By:
    • Nes, Johannes;
    • Gessi, Marco;
    • Sucker, Antje;
    • Möller, Inga;
    • Stiller, Mathias;
    • Horn, Susanne;
    • Scholz, Simone;
    • Pischler, Carina;
    • Stadtler, Nadine;
    • Schilling, Bastian;
    • Zimmer, Lisa;
    • Hillen, Uwe;
    • Scolyer, Richard;
    • Buckland, Michael;
    • Lauriola, Libero;
    • Pietsch, Torsten;
    • Waha, Andreas;
    • Schadendorf, Dirk;
    • Murali, Rajmohan;
    • Griewank, Klaus
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13

    Bevacizumab and temozolomide versus temozolomide alone as neoadjuvant treatment in unresected glioblastoma: the GENOM 009 randomized phase II trial.

    Published in:
    Journal of Neuro-Oncology, 2016, v. 127, n. 3, p. 569, doi. 10.1007/s11060-016-2065-5
    By:
    • Balana, Carmen;
    • De Las Penas, Ramon;
    • Sepúlveda, Juan;
    • Gil-Gil, Miguel;
    • Luque, Raquel;
    • Gallego, Oscar;
    • Carrato, Cristina;
    • Sanz, Carolina;
    • Reynes, Gaspar;
    • Herrero, Ana;
    • Ramirez, Jose;
    • Pérez-Segura, Pedro;
    • Berrocal, Alfonso;
    • Vieitez, Jose Maria;
    • Garcia, Almudena;
    • Vazquez-Estevez, Sergio;
    • Peralta, Sergi;
    • Fernandez, Isaura;
    • Henriquez, Ivan;
    • Martinez-Garcia, Maria
    Publication type:
    Article
    14
    16
    17
    18
    19
    20
    21
    22
    23
    24